Tuberculosis News and Research

Latest Tuberculosis News and Research

Vaping destroys lining and immune cells in the lung, says study

Now, a new study shows that the vapor emitted by the electronic cigarettes is vaping is linked to much higher rates of cell death among airway epithelial cells – more than double, from about 9% in controls to 17-20% in the exposed cells.

24 Sep 2019

IDSA calls for meaningful funding to control current Ebola outbreak

Spending bills released by Senate Appropriations Committee Wednesday demonstrate encouraging recognition of some of the most urgent health challenges threatening individual and public health at home and abroad.

23 Sep 2019

Genetic mutation appears to help people fight off MRSA

Researchers have discovered that people who carry a certain genetic mutation may have a greater chance of fighting off MRSA infections.

18 Sep 2019

Study sheds light on the metabolism of Leishmania parasite

University of York scientists are part of an international team which has discovered how a parasite responsible for spreading a serious tropical disease protects itself from starvation once inside its human host.

17 Sep 2019

Texas Biomed researchers pinpoint important mechanism behind TB/HIV co-infection

Tuberculosis and HIV - two of the world's deadliest infectious diseases - are far worse when they occur together. Now, Texas Biomedical Research Institute researchers have pinpointed an important mechanism at work in this troubling health problem.

13 Sep 2019

Rutgers study finds genetically tractable cause of drug-tolerant tuberculosis

A Rutgers New Jersey Medical School study has found a genetically tractable cause of drug tolerant tuberculosis, paving the way for researchers to develop new drugs to combat the global TB epidemic and cure the disease.

9 Sep 2019

Drug tolerant Tuberculosis could soon be tracked using genes

A team of researchers from the Rutgers New Jersey Medical School have found genetic foot prints of tuberculosis bacteria that are resistant to the commonly used anti-tubercular drugs. This could help scientists develop drugs to combat drug resistance in tuberculosis.

8 Sep 2019

How tuberculosis progresses: genetic factors play a major role

There are almost 1.8 billion people with tuberculosis bacilli in their body, but only about 5% to 15% develop overt infection, usually within 18 months of initial exposure. The reason behind this selective progression has been sought for decades by scientists from a variety of fields.

5 Sep 2019

Study looks into causes of mortality in Zambia

Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

25 Aug 2019

New type of vaccine targets deadly tuberculosis

Australian medical researchers from the Centenary Institute and the University of Sydney have successfully developed and tested a new type of vaccine targeting tuberculosis (TB), the world's top infectious disease killer.

25 Aug 2019

Technologies for TB testing could help millions of patients in poor, remote settings

Affordable technologies for tuberculosis testing could help millions of patients in poverty or remote settings.

19 Aug 2019

Research shows link between long working hours and low life expectancy

Countries which have an average working week that exceeds 48 hours die an average of two years earlier than those that work for 45 hours or less, new research shows.

19 Aug 2019

UniSA researchers discover new way to find and beat superbugs

A team of researchers led by the University of South Australia has discovered a way to find and beat superbugs, providing a critical breakthrough against many deadly infectious diseases.

19 Aug 2019

FDA approves effective new treatment for extremely drug-resistant tuberculosis

Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).

15 Aug 2019

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.

14 Aug 2019

Discovery of molecular mechanism behind spread of leishmania infection

Researchers from the Institut National de la Recherche Scientifique (INRS) have made a breakthrough in understanding the reason behind the virulence of leishmania parasite. The leishmania parasite is responsible for causing leishmaniasis which affects over 12 million people across the globe and is a chronic parasitic disease.

14 Aug 2019

Researchers make scientific breakthrough regarding Leishmania virulence strategy

A team from the Institut National de la Recherche Scientifique has made a scientific breakthrough regarding the virulence strategy employed by the Leishmania parasite to infect cells of the immune system.

12 Aug 2019

New technique protects promising TB vaccine from heat damage

Scientists working on a new tuberculosis vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.

8 Aug 2019

Lung mucosa plays big role in elderly's susceptibility to tuberculosis

Old lungs are not as capable as young lungs of fighting off an infection of the bacteria that causes tuberculosis, placing seniors at a greater risk of developing TB.

8 Aug 2019

Tuberculosis still looms large over a fourth of the world’s people

A new Danish study concludes that a quarter of the people on earth have the tuberculosis bacillus within their bodies. This disease preys on over 10 million people annually, and kills 2 million a year. It is Number 1 on the list of killer diseases, far above AIDS and other infections.

5 Aug 2019